Skip to main content

Advertisement

Log in

Autoimmune hemolytic anemia

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To study the clinico -hematological profile and treatment outcome in children suffering from auto immune hemolytic anemia (AIHA).

Methods

Twelve children were diagnosed with auto immune hemolytic anemia over a period of four years. Direct antiglobulin test was positive in all the cases. Other causes of hemolytic anemia like thalassemia syndromes, hereditary spherocytosis, G6PD deficiency were excluded by appropriate tests. The children were followed up for 6 months to 4 years.

Results

The age ranged from 7 mth to 9 yr with a mean age of 4.51 yr. All patients had pallor as the presenting complaint followed by splenomegaly (83.3%), jaundice (66.7%), fever (50%) and bleeding manifestations (16.7%). 9 patients had primary disease and 3 had secondary disease. Tubercular infection was seen in 2 patients with secondary disease. Jaundice was seen equally in both the groups. Oral prednisolone produced remission in 83.3% cases. 4 patients (3 in primary and one in secondary group) had relapse after initial response. All responded to a second course of steroids but had subsequent relapses and developed a chronic course.

Conclusion

Autoimmune hemolytic anemia is an uncommon cause of hemolytic anemia in children. Tubercular infection is an underlying pathology in cases of secondary autoimmune hemolytic anemia. Although oral steroids induce remission in most of the cases, relapses are common.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Segel GB. Hemolytic anemias resulting from extracellular factors. In Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 17th ed. Philadelphia; Saunders, 2004; 1638–1640.

    Google Scholar 

  2. Schreiber AD, Gill FM, Manno CS. Auto immune hemolytic anemia. In Nathan DG, Orkin SH, eds. Nathan and Oski’s Hematology of Infancy and Childhood 5th ed. Vol.1. Philadelphia, W.B. Saunders Company, 1998; 501–506.

    Google Scholar 

  3. Sokol RJ, Hewitt S, Stamps BK. Auto immune hemolysis: an 18 year study of 865 cases referred to a regional transfusion centre. Br Med J 1982; 282: 2023–2027.

    Article  Google Scholar 

  4. Vaqlio S, Arista MC, Perrone MP, Tomei G, Testi AM, Coluzzi S, Girelli G. Auto immune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion 2007; 47: 50–54.

    Article  Google Scholar 

  5. Naithani R, Agrawal N, Mahapatra M, Pati H, Kumar R, Choudhary VP. Autoimmune hemolytic anemia in India: clinico-hematological spectrum of 79 cases. Hematology 2006; 11: 73–76.

    Article  PubMed  Google Scholar 

  6. Choudhary VP, Passi GR, Pati HP. Clinico hematological spectrum of auto immune hemolytic anemia: An Indian experience. J Assoc of Phys India 1996; 44: 112–114.

    Google Scholar 

  7. Mehrotra TN, Gupta AK. Hemolytic anemia associated with alpha methyl dopa (aldomet) therapy. Indian J Med Sci 1971; 25: 550–551.

    CAS  PubMed  Google Scholar 

  8. Abhyankar SH, Agarwal B, Currimbhoy Z. Auto immune hemolytic anemia. Indian Pediatr 1986; 23: 175–179.

    CAS  PubMed  Google Scholar 

  9. Olieveira MC, Oliveira BM, Murao M, Veira ZM, Gresta LT, Viana MB. Clinical course of autoimmune hemolytic anemia: an observational study. J Pediatr (Rio J) 2006, 82: 58–62.

    Article  Google Scholar 

  10. Adil SN, Burney, Khurshid M. Auto immune hemolytic anemia in visceral leishmaniasis. J Park Med Assoc 1999; 49: 100–101.

    CAS  Google Scholar 

  11. Hochman JA. Auto immune hemolytic anemia associated with Crohn’s disease. Inflamm Bowel Dis 2002; 8: 98–100.

    Article  PubMed  Google Scholar 

  12. Dowes KA, Domen RE, McCarron KF et al. Auto immune hemolytic anemia following DTP vaccination: report of a fatal case and review of literature. Clin Pediatr 2001; 40: 355–358.

    Article  Google Scholar 

  13. Bakshi S, Rao IS, Jain V, Arya LS. Auto immune hemolytic anemia complicating disseminated childhood tuberculosis. Indian J Pediatr 2004; 71: 549–551.

    Google Scholar 

  14. Gupta V, Bhatia BD. Abdominal tuberculosis with auto immune anemia: a case report. Indian J Pediatr 2005; 72: 175–176.

    Article  CAS  PubMed  Google Scholar 

  15. Gottardo NG, Baker DL, Willis FR. Successful induction and maintenance of long-term remission in a child with chronic relapsing auto immune hemolytic anemia using rituximab. Pediatr Hematol Oncol 2003; 20: 557–561.

    Article  PubMed  Google Scholar 

  16. Ramanathan S, Koutts J, Hertzberg MS. Two cases of refractory warm auto immune hemolytic anemia treated with rituximab. Am J Hematol 2005; 78: 123–126.

    Article  CAS  PubMed  Google Scholar 

  17. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High dose cyclophosphamide for refractory auto immune hemolytic anemia. Blood 2002; 100: 704–706.

    Article  CAS  PubMed  Google Scholar 

  18. Heisel MA, Ortega JA. Factors influencing prognosis in childhood autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1983; 5: 147–150.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Gupta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, V., Shukla, J. & Bhatia, B.D. Autoimmune hemolytic anemia. Indian J Pediatr 75, 451–454 (2008). https://doi.org/10.1007/s12098-008-0071-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-008-0071-0

Key words

Navigation